Article
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.
Proceedings of the National Academy of Sciences of the United States of America - 28 Oct 2003
Richards Anna, Kemp Elizabeth J, Liszewski M Kathryn, Goodship Judith A, Lampe Anne K, Decorte Ronny, Müslümanoğlu M Hamza, Kavukcu Salih, Filler Guido, Pirson Yves, Wen Leana S, Atkinson John P, Goodship Timothy H J
Abstract excerpt
Membrane cofactor protein (MCP; CD46) is a widely expressed transmembrane complement regulator. Like factor H it inhibits complement activation by regulating C3b deposition on targets. Factor H mutations occur in 10-20% of patients with hemolytic uremic syndrome (HUS). We hypothesized that MCP mutations could predispose to HUS, and we sequenced MCP coding exons in affected individuals from 30 families. MCP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
